In hyperglycemia, plasma kallikrein (PK) exacerbates hematoma expansion after intracerebral hemorrhage by enhancing collagen binding and inhibiting collagen-induced platelet aggregation, further affecting patient prognosis (29). Here, KLK4 is linked to Hyperglycemia.